Sign inJoin waitlistJoin the waitlist

Shi-Ming Tu

Physician · Renown Medical Center

Credentials: · · · · ·

History

Renown Medical Center
2026–Present

University of Texas M D Anderson Cancer Center
1990–1992
University of Illinois Hospital and Clinics
1987–1990
Washington University School of Medicine
1983–1987
Johns Hopkins University
1979–1983

Research

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
Cancer Research · 1992 · 1,014 citations
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer
Journal of Clinical Oncology · 2004 · 392 citations
Platinum-based chemotherapy for variant castrate-resistant prostate cancer
Clinical Cancer Research · 2013 · 389 citations

Christopher Logothetis
44 papers
Louis Pisters
38 papers
Lance Pagliaro
26 papers
Nizar Tannir
26 papers
Mehmet Bilen
17 papers · 17 as a resident
JK
Jeri Kim
15 papers
Patricia Troncoso
15 papers
RM
Randall Millikan
15 papers
Ana Aparicio
14 papers
Charles Guo
13 papers
Miao Zhang
13 papers
John Ward
11 papers

Clinical trials

A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy
Principal investigator · Recruiting · Phase 1
University of Arkansas
2024–2028
Zoledronate With Atorvastatin in Renal Cell Carcinoma
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2006–2012
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
Study chair · Completed · Phase 2
M.D. Anderson Cancer Center
2004–2014
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Study chair · Terminated · Phase 3
M.D. Anderson Cancer Center
2002